LENSAR Inc LNSR:NASDAQ

RT Quote | NASDAQ | USD
Last | 01/14/22 EST
6.01quote price arrow down-0.12 (-1.96%)
Volume
10,425
52 week range
5.82 - 9.83
Loading...
  • Open5.95
  • Day High6.15
  • Day Low5.91
  • Prev Close6.01
  • 52 Week High9.83
  • 52 Week High Date02/24/21
  • 52 Week Low5.82
  • 52 Week Low Date12/21/21

Key Stats

  • Market Cap65.87M
  • Shares Out10.96M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change0.33

KEY STATS

  • Open5.95
  • Day High6.15
  • Day Low5.91
  • Prev Close6.01
  • 52 Week High9.83
  • 52 Week High Date02/24/21
  • 52 Week Low5.82
  • 52 Week Low Date12/21/21
  • Market Cap65.87M
  • Shares Out10.96M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change0.33

RATIOS/PROFITABILITY

  • EPS (TTM)-2.45
  • P/E (TTM)-2.45
  • Fwd P/E (NTM)-3.70
  • EBITDA (TTM)-20.008M
  • ROE (TTM)-35.76%
  • Revenue (TTM)31.52M
  • Gross Margin (TTM)53.51%
  • Net Margin (TTM)-71.47%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/08/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On LENSAR Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR...
William Link Ph.D.
Independent Chairman of the Board
Nicholas Curtis
Chief Executive Officer, Director
Alan Connaughton
Chief Operating Officer
Thomas Staab II
Chief Financial Officer
Address
2800 Discovery Drive, Suite 100
Orlando, FL
32826
United States

Top Peers

SYMBOLLASTCHG%CHG
TTOO
T2 Biosystems Inc
0.4159+0.0068+1.66%
BIOL
BIOLASE Inc
0.4023-0.0008-0.1985%
SSKN
STRATA Skin Sciences Inc
1.52+0.02+1.33%
CEMI
Chembio Diagnostics Inc
1.09-0.01-0.91%
PDEX
Pro-Dex Inc
25.13+0.92+3.80%